Transcript Status of GAVI proposal

European Region
Global Alliance for Vaccines &
Immunization
Overview on the Implementation
Of the
Introduction of New / Under-used
Vaccines
1
PRESENTATION OUTLINE
•
•
•
•
•
STATUS OF GAVI COUNTRIES
EUROPEAN GAVI WORKING GROUP
TECHNICAL SUPPORT
CHALLENGES
FUTURE PLANS
2
GAVI ELIGIBLE COUNTRIES (N = 11)
Kyrgyzstan; Tajikistan; Uzbekistan; Turkmenistan; Azerbaijan;
Armenia; Georgia; Ukraine; Moldova; Albania; BiH
3
COUNTRY STATUS BEFORE APPLICATION
ICC
EPI.
ASS.
Cold
Chain
IMM.
PLAN
Hep B
Intro
Hib
Burden
Albania
-----
1999
-----
x
May 95
99 - 00
Armenia
-----
1999
1999
x
Nov 99
-----
Azerbaijan
-----
1999
-----
x
-----
-----
BiH
-----
-----
-----
x
1999 (Fed.)
-----
Georgia
-----
1999
1999
x
2000 Limited
-----
X
-----
-----
x
1999 Limited
99-00
Moldova
-----
1996
-----
x
1995
-----
Tajikistan
-----
-----
1999
x
-----
-----
Turkmenista
----n
1999
1999
x
1992 Limited
-----
Ukraine
-----
1996
1996
x
1996 Limited
-----
Uzbekistan
-----
1997
98+99
x
1998 limited
-----
Countries
Kyrgyzstan
4
GAVI Application Status
EURO Region - June 2001
• Immunization Services: 4 countries
– 3 countries approved
– 1 country to resubmit
• Hepatitis B: 10 / 11 countries
– 4 approved
– 3 approved with clarifications
– 2 approved with conditions
– 1 country to resubmit
• Hib - 5 countries :1 approved
5
Strengthening Immunization
Sub-account
Countries
Status
#
additional
children
Armenia
Approved
494
Amount
granted
US $
15,000 x 2
Azerbaijan
Approved
3,280
16,500 x 2
Georgia
Resubmission
-----
-----
Tajikistan
Approved
24,998
125,000 x 2
28,772
313,000
6
Hepatitis B introduction Thru 2002
Country
status
Amount
Approved 351,000 d
10 d Vials
Approved 65,130 d
Armenia
1 d Vial
Azerbaijan Approved 203,225 d
10 d Vial
Condition
-------BiH
Albania
Georgia
Resubmit
5th round
--------
EDA
Value
Oct. 01
166,000
June 01
124,000
June 01
82,000
--------
--------
--------
--------
7
Hepatitis B introduction Thru 2002
Country
status Amount
Kyrgyzstan Appr..
Tajikistan
5th
round
Clarif.
Turkmen.
Clarif
Ukraine
Cond.
Moldova
Uzbekistan Appr.
EDA
Value
400,000d 10dV
79,000d 1dV
--------
In
country
--------
322,400
275,000d 10dV
47,550 1 d Vial
399,000d 10V
99,750d 1dV
--------
--------
313,000
--------
294,000
--------
--------
3,588,000d
10 dV
Oct. 01
1,546,000
--------
8
PRESENT GAVI COMMITMENT
• Immunization services: 3 Countries
– 28,772 additional children
– US $ 313,000 investment
• Hepatitis B introduction
–
–
–
–
–
7 Countries
1,100,000 children
5,508,155 doses of Hep B vaccine
2,850,000 US $
2.6 US $ per child
9
EURO GAVI Working Group
• Partners - WHO, UNICEF, PATH/CVP, VHPB, CDC,
Govt Norway; USAID, DFID, WB, ADB, Gvts
• TOR - To optimize support provided by partners to NIPs, with
focus on Global Fund eligible countries
• Secretariat - WHO EURO
• Meetings - quarterly - schedule with other regional meetings
– Regional workplan review
10
FOCUS of ACTIVITIES
 EPI and cold chain assessments
 Development and finalization of
 multi-year National plan of action
 preparing funding proposal
 hepatitis B plan
 Finalization of documentation for application
 Strengthening National ICC
 Monitoring and evaluation of implementation
process
11
Feedback from the Review Committee
(as of 25 June 2001)
• More substantial information was requested
on:
 Financial Sustainability – Commitments from
Govts & Partners, Financing schemes
 Plans to improve the safety of injection
 Detailed introduction and integration plan for
Hep B, including training, logistics, cold chain
 Vaccine handling and cold chain issues
 Hib burden of disease and introduction plan
 Evidence of progress in the implementation
12
•
•
•
•
•
•
•
•
GAVI PROCESS
A great opportunity
Revitalize EPI and
Review of EPI status of eligible countries
Identify country needs
Develop EPI plans in a more comprehensive way
Establishment of national ICCs
Emphasis on securing provision of vaccines as
well as safety of immunization
Tremendous boost for introduction of Hep B &
Hib
New way of working through partner
collaboration
13
Planned Vaccine Introductions
Countries
Hep B intro.
Planned
Early 2002
Albania
Mid 2001
Armenia
Mid 2001
Azerbaijan
Early 2002
BiH
Early 2002
Georgia
Mid 2001
Kyrgyzstan
Early 2002
Moldova
End 2001
Tajikistan
Turkmenistan End 2001
Early 2002
Ukraine
End 2001
Uzbekistan
Hib Burden
estimation
1999 - 2002
2001 - 2003
----2001 - 2003
----1999 - 2003
2001 - 2003
--------2001 - 2003
-----
Hib Intro.
Planned
2002
2003
----2003
----2003
2003
--------2003
-----
Mol
14
EURO GAVI Workplan
Objectives
• Support remaining countries to complete GAVI
applications (eg. Georgia, Moldova, BiH, Ukr)
• Complete Hib assessments / plans in 5
countries
• Support countries to implement GAVI funding
• Support strengthening ICCs
• Support countries for all EPI activities
Ensure and monitor implementation of
Immunization plans
15
Future areas of support
 VPDs surveillance (focus on Hep B and Hib)
 Monitoring of performances (DQA)
 Quality of services
 Coverage and wastage
 Safety of immunization:
 Injection safety: guidance to revise policies
on injection procedures
 Storage of vaccines, stock management and
vaccines handling: Ensure financial support
for cold chain maintenance and
replacement
 Waste disposal
 AEFI surveillance and response
16